These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 28423617)

  • 21. The effects of curcumin on proliferation, apoptosis, invasion, and NEDD4 expression in pancreatic cancer.
    Su J; Zhou X; Yin X; Wang L; Zhao Z; Hou Y; Zheng N; Xia J; Wang Z
    Biochem Pharmacol; 2017 Sep; 140():28-40. PubMed ID: 28535906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma.
    Liu S; Ma X; Ai Q; Huang Q; Shi T; Zhu M; Wang B; Zhang X
    Urol Oncol; 2013 Aug; 31(6):938-48. PubMed ID: 21993533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SCF(β-TRCP)-mediated degradation of NEDD4 inhibits tumorigenesis through modulating the PTEN/Akt signaling pathway.
    Liu J; Wan L; Liu P; Inuzuka H; Liu J; Wang Z; Wei W
    Oncotarget; 2014 Feb; 5(4):1026-37. PubMed ID: 24657926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas.
    Amodio N; Scrima M; Palaia L; Salman AN; Quintiero A; Franco R; Botti G; Pirozzi P; Rocco G; De Rosa N; Viglietto G
    Am J Pathol; 2010 Nov; 177(5):2622-34. PubMed ID: 20889565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-221 Promotes Capan-2 Pancreatic Ductal Adenocarcinoma Cells Proliferation by Targeting PTEN-Akt.
    Yang W; Yang Y; Xia L; Yang Y; Wang F; Song M; Chen X; Liu J; Song Y; Zhao Y; Yang C
    Cell Physiol Biochem; 2016; 38(6):2366-74. PubMed ID: 27230035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.
    Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM
    Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCDC88A, a prognostic factor for human pancreatic cancers, promotes the motility and invasiveness of pancreatic cancer cells.
    Tanouchi A; Taniuchi K; Furihata M; Naganuma S; Dabanaka K; Kimura M; Watanabe R; Kohsaki T; Shimizu T; Saito M; Hanazaki K; Saibara T
    J Exp Clin Cancer Res; 2016 Dec; 35(1):190. PubMed ID: 27919290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. (‑)‑Epigallocatechin‑3‑gallate induces apoptosis in human pancreatic cancer cells via PTEN.
    Liu S; Xu ZL; Sun L; Liu Y; Li CC; Li HM; Zhang W; Li CJ; Qin W
    Mol Med Rep; 2016 Jul; 14(1):599-605. PubMed ID: 27176210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCL26 is upregulated by nab-paclitaxel in pancreatic cancer-associated fibroblasts and promotes PDAC invasiveness through activation of the PI3K/AKT/mTOR pathway.
    Chen X; An Y; Zhang Y; Xu D; Chen T; Yang Y; Chen W; Wu D; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2021 Apr; 53(5):612-619. PubMed ID: 33764366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disruption of E3 ligase NEDD4 in peripheral neurons interrupts axon outgrowth: Linkage to PTEN.
    Christie KJ; Martinez JA; Zochodne DW
    Mol Cell Neurosci; 2012 Jun; 50(2):179-92. PubMed ID: 22561198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of NEDD4-1, a PTEN regulator, in gastric and colorectal carcinomas.
    Kim SS; Yoo NJ; Jeong EG; Kim MS; Lee SH
    APMIS; 2008 Sep; 116(9):779-84. PubMed ID: 19024597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic function of p34SEI-1 via NEDD4‑1‑mediated PTEN ubiquitination/degradation and activation of the PI3K/AKT pathway.
    Jung S; Li C; Jeong D; Lee S; Ohk J; Park M; Han S; Duan J; Kim C; Yang Y; Kim KI; Lim JS; Kang YS; Lee MS
    Int J Oncol; 2013 Nov; 43(5):1587-95. PubMed ID: 23970032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
    Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
    Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crucial role of the C-terminus of PTEN in antagonizing NEDD4-1-mediated PTEN ubiquitination and degradation.
    Wang X; Shi Y; Wang J; Huang G; Jiang X
    Biochem J; 2008 Sep; 414(2):221-9. PubMed ID: 18498243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of Phospholipase Cε (PLCε) Inhibits Cell Proliferation via Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN)/AKT Signaling Pathway in Human Prostate Cancer.
    Wang X; Fan Y; Du Z; Fan J; Hao Y; Wang J; Wu X; Luo C
    Med Sci Monit; 2018 Jan; 24():254-263. PubMed ID: 29330357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FoxM1B regulates NEDD4-1 expression, leading to cellular transformation and full malignant phenotype in immortalized human astrocytes.
    Dai B; Pieper RO; Li D; Wei P; Liu M; Woo SY; Aldape KD; Sawaya R; Xie K; Huang S
    Cancer Res; 2010 Apr; 70(7):2951-61. PubMed ID: 20332230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
    Shang Y; Wang LQ; Guo QY; Shi TL
    Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN.
    Wang X; Trotman LC; Koppie T; Alimonti A; Chen Z; Gao Z; Wang J; Erdjument-Bromage H; Tempst P; Cordon-Cardo C; Pandolfi PP; Jiang X
    Cell; 2007 Jan; 128(1):129-39. PubMed ID: 17218260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polycomb complex protein BMI-1 promotes invasion and metastasis of pancreatic cancer stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro, and in vivo study.
    Wang MC; Jiao M; Wu T; Jing L; Cui J; Guo H; Tian T; Ruan ZP; Wei YC; Jiang LL; Sun HF; Huang LX; Nan KJ; Li CL
    Oncotarget; 2016 Feb; 7(8):9586-99. PubMed ID: 26840020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal splicing of NEDD4 in myotonic dystrophy type 2: possible link to statin adverse reactions.
    Screen M; Jonson PH; Raheem O; Palmio J; Laaksonen R; Lehtimäki T; Sirito M; Krahe R; Hackman P; Udd B
    Am J Pathol; 2014 Aug; 184(8):2322-32. PubMed ID: 24907641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.